Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2702-2712

Bentham Science Publishers

Access to resources Recommend Favorite

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 530-540

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Anti-Angiogenic Compounds for Application in Tumor Therapy -COP9 Signalosome-Associated Kinases as Possible Targets

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 5, 2008-05 ,pp. : 421-428

Bentham Science Publishers

Access to resources Recommend Favorite

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 807-812

Bentham Science Publishers

Access to resources Recommend Favorite